The first Chinese supplier of heparin sodium which passes the MFDS GMP audit by the Korea Food & Drug Administration and the PMDA GMP on-site inspection by Japan, and holds the GMP certificates issued by BGV in Hamburg, Germany and CFDA in China, as well as the CEP certificate issued by EDQM in Europe; also, the company participated in the revisions of the Chinese Pharmacopoeia (2010/2015), European Pharmacopoeia and United States Pharmacopeia concerning the heparin sodium API; the company is also the only supplier of heparin sodium which attended the heparin sodium expert panel meeting held at the USP headquarters in the United States.